Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37677976> ?p ?o ?g. }

Showing items 1 to 100 of ±134 with 100 items per page.

Q37677976 description "article científic" @default.
Q37677976 description "article scientifique" @default.
Q37677976 description "articolo scientifico" @default.
Q37677976 description "artigo científico" @default.
Q37677976 description "artículu científicu espublizáu en 2014" @default.
Q37677976 description "bilimsel makale" @default.
Q37677976 description "scientific article published on 26 March 2014" @default.
Q37677976 description "vedecký článok" @default.
Q37677976 description "vetenskaplig artikel" @default.
Q37677976 description "videnskabelig artikel" @default.
Q37677976 description "vědecký článek" @default.
Q37677976 description "wetenschappelijk artikel" @default.
Q37677976 description "wissenschaftlicher Artikel" @default.
Q37677976 description "наукова стаття, опублікована в березні 2014" @default.
Q37677976 description "научни чланак" @default.
Q37677976 description "مقالة علمية نشرت في 26 مارس 2014" @default.
Q37677976 name "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 name "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 name "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty." @default.
Q37677976 type Item @default.
Q37677976 label "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 label "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 label "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty." @default.
Q37677976 prefLabel "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 prefLabel "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 prefLabel "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty." @default.
Q37677976 P1433 Q37677976-BF5A7A10-7752-46EA-A5B3-D6B72E018634 @default.
Q37677976 P1476 Q37677976-DF661859-97B9-4E78-B5E1-C3F884EC4EF5 @default.
Q37677976 P2093 Q37677976-0432930E-BA47-4177-9C4F-2B698281280B @default.
Q37677976 P2093 Q37677976-5A608DE9-99F6-4207-BB97-DC14218BC4D9 @default.
Q37677976 P2093 Q37677976-B0345639-3F2E-4E39-B7B6-EEDCB395692B @default.
Q37677976 P2093 Q37677976-B83F9E32-E5C8-4826-B6FE-564E0611FCBF @default.
Q37677976 P2093 Q37677976-C62B9282-4C5C-43CD-8129-7EBE1153CFE2 @default.
Q37677976 P2093 Q37677976-CCD3E556-A5D4-4D36-86C4-A5E5247382AA @default.
Q37677976 P2093 Q37677976-DC0718F3-38F7-4270-BB4A-CEA8951F4341 @default.
Q37677976 P2093 Q37677976-E51D2C73-388B-470B-8906-5073E6B1E1A8 @default.
Q37677976 P275 Q37677976-c119d83d-3279-4252-860c-b7e63bdc7d97 @default.
Q37677976 P2860 Q37677976-03B352FC-19D3-4B36-AC0A-EA5B873F2FB9 @default.
Q37677976 P2860 Q37677976-1A2A580A-91F5-48E6-85FA-00198F46A124 @default.
Q37677976 P2860 Q37677976-1D6B3B39-C7BF-451F-A695-83E0CA1CE56D @default.
Q37677976 P2860 Q37677976-2DB55332-D120-4DEB-9FEA-C8C6A21E54CF @default.
Q37677976 P2860 Q37677976-31E97F48-762A-4048-A93F-5EFA5D82D241 @default.
Q37677976 P2860 Q37677976-5440058B-AFC2-4622-B2C5-9ECA0F29B425 @default.
Q37677976 P2860 Q37677976-5A6DD57C-608A-4C2F-BA80-0BDD71BCED92 @default.
Q37677976 P2860 Q37677976-5D5CEBE1-2FAF-4A96-8C15-4D96AD0F249F @default.
Q37677976 P2860 Q37677976-619D7C72-0B46-4DAF-A15E-5C260076ACAA @default.
Q37677976 P2860 Q37677976-64C154B2-9AA0-4E2C-AF5E-66A0A12646D1 @default.
Q37677976 P2860 Q37677976-748D95A9-B59F-4B7F-A4B0-7E1559D7BBA7 @default.
Q37677976 P2860 Q37677976-7C5F9BCC-CB46-4654-B3DB-2CB9DA002AC6 @default.
Q37677976 P2860 Q37677976-7E4BDBF1-EC79-4202-8C4C-24C90A18A142 @default.
Q37677976 P2860 Q37677976-8372C3B6-1265-43A6-A13D-47547056EFFE @default.
Q37677976 P2860 Q37677976-8EBBEDF5-1611-4B67-AEB0-A6D213927BE5 @default.
Q37677976 P2860 Q37677976-8F5F6E3B-8F77-4C8E-9D10-588FB2330090 @default.
Q37677976 P2860 Q37677976-99546187-7379-4B3E-A5C9-A97247DE9DF5 @default.
Q37677976 P2860 Q37677976-9E436EB6-BE37-4E6D-9970-A13B91940D05 @default.
Q37677976 P2860 Q37677976-9E65392E-98AA-49D2-ADAF-93375EB4A908 @default.
Q37677976 P2860 Q37677976-B31CECD2-7DDA-47FA-8147-544A5EE85235 @default.
Q37677976 P2860 Q37677976-B91DDA09-E123-4434-B74F-2DA4F2E7848A @default.
Q37677976 P2860 Q37677976-BA09792D-7F63-4003-9313-9DD011FE40D5 @default.
Q37677976 P2860 Q37677976-C172CD5A-8713-4256-BB5F-6CB24A0556E3 @default.
Q37677976 P2860 Q37677976-C25A1FF4-EA32-4942-967C-F763FBB7B0ED @default.
Q37677976 P2860 Q37677976-C7427250-FEC1-491C-8C81-537D4A0F56B3 @default.
Q37677976 P2860 Q37677976-CB74F0A4-56DD-4654-8FBA-F90C9519837C @default.
Q37677976 P2860 Q37677976-D24FBC90-49CE-45B9-9B4A-031BCD26F842 @default.
Q37677976 P2860 Q37677976-D8A08C70-DF89-45DC-8268-48293F81C154 @default.
Q37677976 P2860 Q37677976-E9234534-A864-4020-A7EA-24FEC2E0A23A @default.
Q37677976 P2860 Q37677976-EFFE09B5-E4C7-4F73-9771-42DCD8B0A963 @default.
Q37677976 P304 Q37677976-AF96131B-D0D2-4838-AFAC-F6B0697F12B2 @default.
Q37677976 P31 Q37677976-46E47E07-50A6-41A6-A036-1725A6E7689C @default.
Q37677976 P356 Q37677976-0832AC6B-FFBA-4B1F-A2DA-26D50214CA7D @default.
Q37677976 P407 Q37677976-71631B35-124C-461D-8C14-74DFF28C6120 @default.
Q37677976 P478 Q37677976-ACF05EF8-A8AC-4308-8067-3A83841A743E @default.
Q37677976 P50 Q37677976-4CA50E3C-C439-4B19-A103-D4083074AAB9 @default.
Q37677976 P577 Q37677976-8A2A7D62-699C-4BCC-BEEC-76EB961ACAEF @default.
Q37677976 P5875 Q37677976-DC99D599-AB84-4F25-9059-42DBCB1C9D3E @default.
Q37677976 P6216 Q37677976-064f8bc8-c28c-403f-a7f3-da1a929d423c @default.
Q37677976 P698 Q37677976-177CC8DF-129B-40F8-9144-C704D1C8FCAB @default.
Q37677976 P921 Q37677976-78F989BD-E476-4046-850F-ABD020E55323 @default.
Q37677976 P932 Q37677976-6C2B970A-60C3-42E5-8B19-AB5F29C6B22B @default.
Q37677976 P356 VHRM.S54714 @default.
Q37677976 P698 24707185 @default.
Q37677976 P1433 Q7916443 @default.
Q37677976 P1476 "Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty" @default.
Q37677976 P2093 "Alexander G G Turpie" @default.
Q37677976 P2093 "Bennett Levitan" @default.
Q37677976 P2093 "Jesse A Berlin" @default.
Q37677976 P2093 "Martin Homering" @default.
Q37677976 P2093 "Peter M DiBattiste" @default.
Q37677976 P2093 "Rachel B Weinstein" @default.
Q37677976 P2093 "Richard J Friedman" @default.
Q37677976 P2093 "Zhong Yuan" @default.
Q37677976 P275 Q18810331 @default.
Q37677976 P2860 Q24632872 @default.
Q37677976 P2860 Q26995635 @default.
Q37677976 P2860 Q34207019 @default.
Q37677976 P2860 Q34252907 @default.
Q37677976 P2860 Q34323100 @default.
Q37677976 P2860 Q34607209 @default.
Q37677976 P2860 Q34646508 @default.
Q37677976 P2860 Q34789112 @default.